Severe Hypokalemia Probably Associated With Sertraline Use

Annals of Pharmacotherapy

Volumn 48, Issue 2, 2014, Pages 297-300

  Izgi, Cemil ^a   Erdem, Guliz ^b   Mansuroglu, Denyan ^a   Kurtoglu, Nuri ^a   Kara, Mujdat ^a   Gunesdogdu, Fusun ^a  

^a Gaziosmanpasa Hospital   (Turkey)

^b MEMORIAL HOSPITAL   (Turkey)

Author keywords

adverse drug reaction; hypokalemia; prolonged QT; sertraline

Indexed keywords

HERBACEOUS AGENT; MAGNESIUM; POTASSIUM; SERTRALINE;

ADRENAL GLAND; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CHEMISTRY; CASE REPORT; DISEASE SEVERITY; DRUG USE; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; ELECTROLYTE BLOOD LEVEL; HEART ARREST; HEART VENTRICLE FIBRILLATION; HUMAN; HYPOKALEMIA; MALE; MIDDLE AGED; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; QT INTERVAL;

ADVERSE DRUG REACTION; HYPOKALEMIA; PROLONGED QT; SERTRALINE;

ANTIDEPRESSIVE AGENTS; HEART ARREST; HUMANS; HYPOKALEMIA; MALE; MIDDLE AGED; POTASSIUM; SERTRALINE; VENTRICULAR FIBRILLATION;

EID: 84893328046     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028013512789     Document Type: Article

References (13)

1. Kelly WN,Arellano FM,Barnes J,et al.Guidelines for submitting adverse event reports for publication.Pharmacoepidemiol Drug Saf. 2007;16:581-587.
2. eHealthMe. Real World Drug Outcomes. http://www.ehealthme.com/ds/sertraline/hypokalaemia/. Accessed May 2, 2013.
3. Naranjo CA,Busto U,Sellers EM,et al.A method for estimating the probability of adverse drug reactions.Clin Pharmacol Ther. 1981;30:239-245.
4. Glassman AH,O'Connor CM,Califf RM,et al.Sertraline treatment of major depression in patients with acute MI or unstable angina.JAMA. 2002;288:701-709.
5. FDA Drug safety communication: Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses. http://www.fda.gov/drugs/drugsafety/ucm297391.htm. Accessed May 3, 2013.
6. de Boer RA,van Dijk TH,Holman ND,van Melle JP.QT interval prolongation after sertraline overdose: a case report.BMC Emerg Med. 2005;5:5.
7. Matsumoto H.Hyponatremia associated with selective serotonin reuptake inhibitors.Intern Med. 2005;44:173-174.
8. Blenkinsopp A,Wilkie P,Wang M,Routledge PA.Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.Br J Clin Pharmacol. 2007;63:148-156.
9. Kane MP,Busch RS.Drug-induced thyrotoxic periodic paralysis.Ann Pharmacother. 2006;40:778-781.
10. Klein-Schwartz W,Anderson B.Analysis of sertraline-only overdoses.Am J Emerg Med. 1996;14:456-458.
11. Catalano MC,Catalano G,Kanfer SN,Toner LC,Stock SL,Taylor WD.The effect of sertraline on routine blood chemistry values.Clin Neuropharmacol. 2000;23:267-270.
12. Shang CY,Soong WT,Lin HN.Hypokalemia with venlafaxine.J Clin Psychiatry. 2002;63:1049-1050.
13. Kjeldsen K.Hypokalemia and sudden cardiac death.Exp Clin Cardiol. 2010;15:e96-e99.